Ping Zou

Expressions of tissue factor and tissue factor pathway inhibitor in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Y. You, P. 萍, Weiming Li, 2009, Journal of Huazhong University of Science and Technology [Medical Sciences].

Idarubicin-intensified BUCY2 regimens may lower relapse rate and improve survival in patients undergoing allo-SCT for high-risk hematological malignancies: a retrospective analysis

P. Zou, L. Xia, Z. Zhong, 2012, Bone Marrow Transplantation.